Raymond James Financial’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Raymond James Financial's TARS Position: Q3 2026 in Review
Raymond James Financial reduced its Tarsus Pharmaceuticals (TARS) stake by 11% in Q3 2026, selling an estimated $239K and leaving 26,506 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3475.
Raymond James Financial first reported a position in TARS in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.93M in Q3 2025. 176 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Raymond James Financial held 26,506 shares of Tarsus Pharmaceuticals worth $2.08M as of Q3 2026.
- Raymond James Financial sold 3,439 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $239K.
- Tarsus Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3475 holding.
- Raymond James Financial first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Tarsus Pharmaceuticals position peaked at $2.93M in Q3 2025.
- 176 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.